Loading: 100%
Natera, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 852 (as per Q2 2016)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker NTRAno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1768101214
datesClosing price (adj.)
13.10.201713.21
11.10.201713.18
04.10.201713.78
27.09.201712.27
20.09.201712.63
13.09.201713.26
06.09.201712.78
30.08.201712.02
23.08.201711.35
16.08.201711.27
09.08.201710.35
02.08.20178.10
26.07.20178.75
19.07.201710.71
12.07.201711.01
05.07.201710.88
27.06.201711.04
20.06.201710.66
13.06.201710.71
06.06.201710.25
30.05.201710.32
23.05.201710.23
16.05.201710.53
09.05.20179.16
02.05.20179.49
25.04.20178.62
18.04.20178.15
11.04.20177.68
04.04.20178.61
28.03.20178.83
21.03.20178.64
14.03.20178.47
07.03.20179.87
28.02.20179.56
21.02.20179.78
14.02.20179.87
07.02.20179.19
31.01.20178.96
24.01.20179.15
17.01.20179.85
10.01.201711.83
03.01.201711.89
27.12.201611.83
19.12.201611.76
12.12.201611.74
05.12.201611.87
28.11.201612.00
21.11.201612.00
14.11.201611.60
07.11.20169.00
31.10.20168.48
24.10.20169.95
17.10.201610.36
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
13.21n/a
Market Capitalisation
in million USD
684n/a
Enterprise Value
in million USD
518n/a
Common Shares Outstanding
as per Jul 31, 2016
51,781,811n/a
Preferred Shares Outstanding
as per Jul 31, 2016
n/a
Average Basic Shares Outstanding
TTM
48,979,250n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 215n/a
Receivables 6n/a
Total Current Assets 237n/a
PP&E 19n/a
Total Assets 261n/a
Accounts Payable 9n/a
Current Debt 49n/a
Total Current Liabilities 95n/a
Long-Term Debt 0n/a
Total Liabilities 97n/a
Total Equity 164n/a
Cash Flow
Depreciation & Amortisation 5n/a
Change in Working Capital 10n/a
Operating Cash Flow -42n/a
Net Change in PP&E and Intangibles -8n/a
Investing Cash Flow -207n/a
Dividends Paid 0n/a
Financing Cash Flow 204n/a
Total Change in Cash -46n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 3.34n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 3.95n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.24n/a
Other Ratios
Current Ratio 248.4%n/a
Liabilities to Equity Ratio 59.5%n/a
Debt to Assets Ratio 18.9%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Revenue
55
159
190
Sales & Services Revenue
0
0
0
Financing Revenue
0
0
0
Other Revenue
0
0
0
Cost of revenue
-37
-78
-113
Cost of Goods & Services
0
0
0
Cost of Financing Revenue
0
0
0
Cost of Other Revenue
0
0
0
Gross Profit
18
81
78
Other Operating Income
0
0
0
Operating Expenses
-43
-80
-137
Selling, General & Administrative
-32
-63
-110
Selling & Marketing
0
0
0
General & Administrative
0
0
0
Research & Development
-12
-17
-28
Depreciation & Amortization
0
0
0
Provision For Doubtful Accounts
0
0
0
Other Operating Expense
0
0
0
Operating Income (Loss)
-25
1
-60
Non-Operating Income (Loss)
4
6
10
Interest Expense, net
4
6
10
Interest Expense
0
0
0
Interest Income
0
0
0
Other Investment Income (Loss)
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
Income (Loss) from Affiliates
0
0
0
Other Non-Operating Income (Loss)
0
0
0
Pretax Income (Loss), Adjusted
-21
6
-49
Abnormal Gains (Losses)
8
0
0
Acquired In-Process R&D
0
0
0
Merger / Acquisition Expense
0
0
0
Abnormal Derivatives
0
0
0
Disposal of Assets
0
0
0
Early extinguishment of Debt
0
0
0
Asset Write-Down
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
Sale of Business
0
0
0
Legal Settlement
0
0
0
Restructuring Charges
0
0
0
Sale of and Unrealized Investments
0
0
0
Insurance Settlement
0
0
0
Other Abnormal Items
0
0
0
Pretax Income (Loss)
-13
6
-49
Income Tax (Expense) Benefit, net
0
0
0
Current Income Tax
0
0
0
Deferred Income Tax
0
0
0
Tax Allowance/Credit
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
Income (Loss) from Continuing Operations
-13
6
-49
Net Extraordinary Gains (Losses)
0
0
0
Discontinued Operations
0
0
0
XO & Accounting Charges & Other
0
0
0
Income (Loss) Including Minority Interest
-13
6
-49
Minority Interest
0
0
0
Net Income
-13
6
-49
Preferred Dividends
0
0
0
Other Adjustments
0
0
0
Net Income Available to Common Shareholders
-13
6
-49
Remarks
restated on Mar 24, 2016 n/a
calculated values,
restated on Mar 24, 2016 n/a
calculated values,
restated on Mar 24, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
87
231
Cash & Cash Equivalents
n/a
87
29
Short Term Investments
n/a
0
202
Accounts & Notes Receivable
n/a
6
6
Accounts Receivable, Net
n/a
6
6
Notes Receivable, Net
n/a
0
0
Unbilled Revenues
n/a
0
0
Inventories
n/a
12
8
Raw Materials
n/a
0
0
Work In Process
n/a
0
0
Finished Goods
n/a
0
0
Other Inventory
n/a
0
0
Other Short Term Assets
n/a
2
6
Prepaid Expenses
n/a
1
5
Derivative & Hedging Assets
n/a
0
0
Assets Held-for-Sale
n/a
0
0
Deferred Tax Assets
n/a
0
0
Income Taxes Receivable
n/a
0
0
Discontinued Operations
n/a
0
0
Miscellaneous Short Term Assets
n/a
1
1
Total Current Assets
n/a
106
251
Property, Plant & Equipment, Net
n/a
15
13
Property, Plant & Equipment
n/a
0
0
Accumulated Depreciation
n/a
0
0
Long Term Investments & Receivables
n/a
0
0
Long Term Investments
n/a
0
0
Long Term Marketable Securities
n/a
0
0
Long Term Receivables
n/a
0
0
Other Long Term Assets
n/a
3
2
Intangible Assets
n/a
0
0
Goodwill
n/a
0
0
Other Intangible Assets
n/a
0
0
Prepaid Expense
n/a
0
0
Deferred Tax Assets
n/a
0
0
Derivative & Hedging Assets
n/a
0
0
Prepaid Pension Costs
n/a
0
0
Discontinued Operations
n/a
0
0
Investments in Affiliates
n/a
0
0
Miscellaneous Long Term Assets
n/a
3
2
Total Noncurrent Assets
n/a
17
15
Total Assets
n/a
124
265
Liabilities and owners' equity
Payables & Accruals
n/a
25 25188000
35 34592000
Accounts Payable
n/a
9 8867000
7 7332000
Accrued Taxes
n/a
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
Other Payables & Accruals
n/a
16 16321000
27 27260000
Short Term Debt
n/a
2 2340000
42 42090000
Short Term Borrowings
n/a
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
Other Short Term Liabilities
n/a
2 2344000
4 3793000
Deferred Revenue
n/a
0 112000
0 144000
Derivatives & Hedging
n/a
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
2 2232000
4 3649000
Total Current Liabilities
n/a
30 29872000
80 80475000
Long Term Debt
n/a
4 3510000
0 0
Long Term Borrowings
n/a
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
Other Long Term Liabilities
n/a
21 20772000
0 0
Accrued Liabilities
n/a
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
Pensions
n/a
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
21 20772000
0 0
Total Noncurrent Liabilities
n/a
24 24282000
0 0
Total Liabilities
n/a
54 54154000
80 80475000
Preferred Equity
n/a
241 240612000
0 0
Share Capital & Additional Paid-In Capital
n/a
9 8665000
436 436264000
Common Stock
n/a
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
Other Share Capital
n/a
0 0
0 0
Treasury Stock
n/a
0 0
0 0
Retained Earnings
n/a
-180 -179808000
-250 -250083000
Other Equity
n/a
0 0
-1 -1416000
Equity Before Minority Interest
n/a
69 69469000
185 184765000
Minority Interest
n/a
0 0
0 0
Total Equity
n/a
69 69469000
185 184765000
Total Liabilities & Equity
n/a
124 123623000
265 265240000
Remarks restated on n/a restated on Mar 24, 2016 n/a restated on Aug 11, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Net Income/Starting Line
-37
-5
-70
Net Income
0
0
0
Net Income From Discontinued Operations
0
0
0
Other Adjustments
0
0
0
Depreciation & Amortization
3
5
6
Non-Cash Items
12
7
17
Stock-Based Compensation
0
0
0
Deferred Income Taxes
0
0
0
Other Non-Cash Adjustments
0
0
0
Change in Working Capital
-2
3
10
(Increase) Decrease in Accounts Receivable
0
0
0
(Increase) Decrease in Inventories
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
Increase (Decrease) in Other
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
Cash from Operating Activities
-24
10
-38
Change in Fixed Assets & Intangibles
-8
-10
-7
Disposition of Fixed Assets & Intangibles
0
0
0
Disposition of Fixed Assets
0
0
0
Disposition of Intangible Assets
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
Purchase of Fixed Assets
0
0
0
Acquisition of Intangible Assets
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
Net Change in Long Term Investment
0
0
-203
Decrease in Long Term Investment
0
0
0
Increase in Long Term Investment
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
Net Cash from Divestitures
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
Cash for Joint Ventures
0
0
0
Net Cash from Other Acquisitions
0
0
0
Other Investing Activities
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
Cash from Investing Activities
-8
-10
-211
Dividends Paid
0
0
0
Cash From (Repayment of) Debt
25
3
196
Cash From (Repayment of) Short Term Debt, net
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
Repayments of Long Term Debt
0
0
0
Cash From Long Term Debt
0
0
0
Cash From (Repurchase of) Equity
33
55
1
Increase in Capital Stock
33
55
1
Decrease in Capital Stock
0
0
0
Other Financing Activities
-1
-2
-7
Net Cash From Discontinued Operations (financing)
0
0
0
Cash from Financing Activities
57
56
190
Net Cash Before Disc. Operations and FX
25
57
-58
Change in Cash from Disc. Operations and Other
0
0
0
Net Cash Before FX
25
57
-58
Effect of Foreign Exchange Rates
0
0
0
Net Changes in Cash
25
57
-58
Remarks
restated on Mar 24, 2016 n/a
calculated values,
restated on Mar 24, 2016 n/a
calculated values,
restated on Mar 24, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo